Despite this large number of women affected by cardiovascular disease, women and minorities are underrepresented in cardiovascular clinical trials. Only one-third of cardiovascular clinical trials report sex-specific results, making it ever more difficult for researchers and clinicians to know how a particular drug or device will affect women.
We all appreciate the elegance of simple solutions to complex problems. But we know too that simplicity can often masquerade as truth, hiding a more nuanced reality. Such is the case with inflammation, where pseudoscience, exaggerated claims, false promises, and dangerous oversimplification have dominated for too long.
If we want to have a chance to improve cardiovascular outcomes in the Latino community, we have to center our efforts on the heads of the families, Latinas. That being said, it is also important to understand that they will take care of everyone around them before attending to their own needs. For the benefit of our community, that has to change.